Department of Defense (DoD) Health Program research opportunities are posted below. Grants with the shortest deadlines or that require pre-applications are posted first.

Contact the UAMS Office of Research for information on application tips, current UAMS DoD funding  grantees, and UAMS DoD reviewers. Contact the Office of Research and Sponsored Programs for submission assistance, eligibility questions, or other grant funding questions.


Department of Defense Prostate Cancer Research Program (PCRP)
The PCRP seeks to develop treatments to improve prostate cancer outcomes, reduce prostate cancer in African Americans, Veterans, and high-risk populations, define prostate cancer biology, and improve survivors quality of life.

DEADLINE: June 6, 2019 (Pre-proposal due); September 19, 2019 (full application due)
Idea Award – Max funding $750,000 for direct/indirect costs. New Investigators – Max funding $600,000 (direct/indirect costs) for 3 yrs.

DEADLINE: June 6, 2019 (Pre-proposal due); June 27, 2019 (full application deadline)
Early Investigator Award – Max funding $200,000 (direct/indirect costs) for 2 years.
Physician Research Award – Max funding $750,000 (direct/indirect costs) for 4 years.

DEADLINE: June 27, 2019 (Pre-proposal due); July 18, 2019 (full application due)
Clinical Trial Award – Early-phase clinical trials (e.g., Phase 0, Phase I, pilot Phase II) to
test interventions. Max funding $2,000,000 (direct/indirect costs) for 4 yrs.
Health Disparity Research Award – Max funding $750,000 (direct/indirect costs); New Investigators – Max funding $600,000 (direct/indirect costs) for 3 yrs.
Synergistic Population and Data Science Award – Max funding $1,500,000 (direct/indirect costs) for 4 yrs.
Translational Science Award – Max funding $750,000 for direct/indirect costs for 3 yrs.

Synopsis

__________________
Department of Defense Epilepsy Research Program (ERP) and Idea Development Award
DEADLINE: June 26, 2019 (Letter of Intent); July 17, 2019 (full application deadline)
The ERP FY19 Focus Areas are in Basic Research (e.g.,  biomarkers, therapeutic targets, early detection); Epidemiology (e.g., risk factors); and Longitudinal Studies (e.g., seizure frequency/severity, anatomy/pathology, injury type, depression, sleep disorders). Max funding of $300,000 – Level I for direct/indirect costs for 3 yrs. and $500,000 – Level II for 3 yrs.

Synopsis

___________________
Department of Defense Peer Reviewed Orthopaedic Research Program (PRORP)
DEADLINE: June 26, 2019 (Pre-proposal due); September 18, 2019 (full application deadline – by invitation)
PRORP’s Applied Research Award seeks research in the following FY19 focus areas:  1) Compartment Syndrome Models, Limb Stabilization and Protection; 2) Rapid Limb Stabilization/Wound Protectants; 3) Retention on Duty Strategies; 4) Skin-implant Interface; 5) Translation of Early Findings to Clinical Trials/practice; and 6) Tissue Regeneration Therapeutics. Max funding of $750,000 for total costs (direct/indirect costs) for 3 yrs.
Clinical Trial Award  Same focus areas/deadline. Max funding of $2.5 million – Level I (direct/indirect costs) for 4 yrs. and max funding of $3M (direct/indirect) for 4 yrs.
Clinical Translational Research Award  Same focus areas/deadline. Max funding of $2M  (direct/indirect costs) for 4 yrs.

Synopsis
___________________
Department of Defense Peer Reviewed Alzheimer’s Research Program
DEADLINE: June 26, 2019 (Letter of Intent); July 17, 2019 (Full application deadline)
The DoD Peer Reviewed Alzheimer’s Research Program (PRARP) supports research on long-term consequences of traumatic brain injury for Alzheimer’s disease/dementias via 3 award mechanisms – Convergence Science Research Award, Innovation in Care and Support Award, and Research Partnership Award.  Topical areas include: Paucity of Research Resources; Paucity of Clinical Studies; Diagnostics/Prognostics; Epidemiology; Quality of Life; and Family/Care Support. Max funding of Level I – $225,000 (direct/indirect) costs for 3 yrs.  Level II – Max funding of $500,000 (direct/indirect costs) for 3 yrs.

Synopsis

___________________
Department of Defense Melanoma Research Program
DEADLINE: June 26, 2019 (Pre-proposal due); October 23, 2019 (Full application deadline)
The DoD Melanoma Research Program (MRP) supports innovative, high-impact melanoma research (e.g., precursor lesions, melanomagenesis, host factors, tumor microenvironment/evolution; therapeutic prevention: residual disease; rare melanomas). Funding via:  Idea Awards – $300,000 (direct/indirect costs) for 3 yrs; Team Science Awards (2-3 investigators must partner in a multidisciplinary research study), $700,000 (direct/indirect) costs for 3 yrs; and Translational Research Awards support studies with existing biobanks, biorepositories, ongoing/completed clinical trials on translational melanomas. DoD/VA participation encouraged, preliminary data required, and new clinical trials not allowed $600,000 (direct/indirect costs) for 3 yrs.

Synopsis
___________________

Department of Defense Gulf War Illness Research Program
DEADLINE: July 12, 2019 (Pre-application required; October 3, 2019 (full application deadline – by invitation)

The Department of Defense Gulf War Illness Research Program (GWIRP) supports research in Gulf War Illness pathobiology, diagnosis, and treatment.

Idea Award – Max funding $150,000 for direct/indirect costs. Max funding of $170,000 (direct/indirect costs) Biorepository Contribution Option; Max period 2 yrs.

Clinical Evaluation Award – Max funding $1,000,000 (direct/indirect costs); Max funding $1,020,000 (direct/indirect costs) with Biorepository Contribution. Max funding $1,200,000 (direct/indirect costs) with Clinical Consortium Collaboration for 3 yrs.

Therapeutic/Biomarker Trial Award – Max funding $5,000,000 (direct/indirect costs); Max funding $5,020,000 (direct/indirect costs) for Biorepository Contribution; Max funding $5,500,000 (direct/indirect costs) Clinical Consortium Collaboration for 4 yrs.

Patient-Provider and Health Communications Award – Max funding $700,000 (direct/indirect costs) for 3 yrs.

New Investigator Award – 3 eligibility categories: Transitioning Postdoc; Postdoc (3 yrs of postdoc  training); Early-Career Investigator (5 yrs since last training position); New GWI researcher (Established PI with less than $300,000 in federally funded, non-mentored GWI research). GWI researchers collaborations strongly encouraged. Preliminary data not required; Clinical trials not allowed. Max funding $500,000(direct/indirect costs); Max funding $520,000 (direct/indirect costs) with Biorepository Contribution.

Research Advancement Award – Max funding $700,000 for direct/indirect costs. Max funding $720,000 (direct/indirect costs) Biorepository Contribution for 3 yrs.

Synopsis

___________________
DEPSCoR: Defense Established Programs to Stimulate Competitive Research
U.S. Army YIP is a rolling acceptance program with no fixed suspense date.
DEADLINE: Air Force YIP – June 3, 2019.
DEADLINE: Navy YIP – to be announced soon.

The Army Research Office (ARO), Air Force Office of Scientific Research (AFOSR), and Office of Naval Research (ONR) build facility capacity/increase research infrastructure. DEPSCoR augments existing programs in DEPSCoR-eligible states/territories. Specifically: Young Investigator Program (YIP) and the Defense University Research Instrumentation Program (DURIP).

(1) Helps higher education develop science and engineering (S&E) research relevant to DoD mission; (2) Increase university researchers doing S&E research in eligible states/territories; and (3) Increase long-term growth in eligible states/territories that receive federal S&E funding.

___________________
Department of Defense Reconstructive Transplant Research (RTRP)
The RTR seeks to advance the science and execution of complex hand, face and other vascularized composite allotransplantation (VCA) procedures.

DEADLINE: July 17, 2019 (Pre-applicaton due); October 16, 2019 (full application by invitation)
Idea Discovery Award – Max funding $500,000 for direct/indirect costs for 2 yrs.
Investigator-Initiated Research Award – Max funding $1 million (direct/indirect costs) for 3 years.

Synopsis 

___________________
Department of Defense Lung Cancer Research Program (LCRP) 

The LCRP seeks to identify innovative strategies for the early detection of lung cancer; understand the molecular mechanisms, prevention, treatment, and recurrence of lung cancer.

DEADLINE: July 24, 2019 (Letter of Intent due); August 7, 2019 (full application due)
Concept Award – Max funding $100,000 for direct/indirect costs. for 1 yr. Clinical trials not allowed. Relevance to Military Health strongly encouraged.

DEADLINE: August 1, 2019 (Pre-proposal due); August 21, 2019 (full application deadline)
Career Development Award – Max funding $250,000 (direct/indirect costs) for 2 years.

Synopsis

___________________
Department of Defense Vision Research Program 
DEADLINE: August 6, 2019 (Pre-proposal due); December 6, 2019 (Full application deadline – by invitation)
The VRP supports military vision research in: Eye injury or visual dysfunction; Blast, blunt, thermal, or chemical trauma; Trauma caused by directed energy weapons; Diagnosis/treatment of eye injuries in austere environment.

Investigator-Initiated Research Award – Level I Max funding $260,000 (direct/indirect costs) for 2 yrs. Level II Max funding $500,000 (direct/indirect costs) for 3 years.

Translational Research Award – Max funding of $750,000 (direct/indirect costs) for 3 yrs.

Focused Translational Team Science Award – Lead PI is required to have minimum 20% effort. Applications must include 3-5 five distinct research projects. Max funding $5,000,000 (direct/indirect costs) for 4 yrs.

Synopsis

__________________
Department of Defense Peer Reviewed Breast Cancer Research Program (BCRP)
DEADLINE: August 22, 2019 (Letter of Intent); September 5, 2019 (full application deadline)
The BCRP FY19 Focus Areas are Level I – Early stage, high risk/high-reward research; Level II – Preclinical research supported by substantial preliminary/published data with clinical translation partnering; and Level II – Population science and prevention studies. Level I – Max funding of $450,000 ($750,000 with partnering) for direct/indirect costs for 3 yrs. Level II – Max funding of $1 million ($1.5 million with partnering) for direct/indirect costs for 3 yrs. Level II Population science and prevention studies – Max funding of $1.5 million ($2 million with partnering) for direct/indirect costs for 4 yrs.

Synopsis

___________________
Department of Defense Kidney Cancer Research Program (KCRP)
The KCRP Concept Award supports highly innovative, untested, novel concepts in kidney cancer.
DEADLINE: September 17, 2019 (Letter of Intent due); October 1, 2019 (full application due)
Concept Award – Maximum funding of $75,000 for direct/indirect costs for 1 yr. Clinical trials not allowed. Preliminary data not allowed.
Idea Development Award – Preliminary data required. Clinical trials not allowed. Maximum funding of $400,000 in direct/indirect costs for 2 yrs.
Translational Research Partnership Award -Maximum funding of $600,000 for direct/indirect costs for 3 yrs. Supports partnerships between clinicians/scientists that accelerate kidney cancer clinical applications; Supports translational correlative studies; Preliminary data required; Clinical trials not allowed.

Synopsis

_____________________
Department of Defense Clinical and Rehabilitative Medicine Research Program
The (JPC-8/CRMRP) supports the development of regenerative medicine solutions and technical capabilities that repair, reconstruct, or regenerate tissue lost or damage due to traumatic injury through collaborative partnerships and synergistic projects. All projects will be required to address peripheral nerve and/or skeletal muscle regeneration.

DEADLINE: August 7, 2019 (Preapplication due); November 20, 2019 (full application due) Max funding of $10 million for direct/indirect costs for 5 yrs.

Synopsis 

______________________